557 related articles for article (PubMed ID: 27777022)
41. Contribution of homozygous and compound heterozygous missense mutations in VWA2 to Alzheimer's disease.
Hoogmartens J; Hens E; Engelborghs S; Vandenberghe R; De Deyn PP; Cacace R; Van Broeckhoven C;
Neurobiol Aging; 2021 Mar; 99():100.e17-100.e23. PubMed ID: 33023779
[TBL] [Abstract][Full Text] [Related]
42. Genetic testing in familial and young-onset Alzheimer's disease: mutation spectrum in a Serbian cohort.
Dobricic V; Stefanova E; Jankovic M; Gurunlian N; Novakovic I; Hardy J; Kostic V; Guerreiro R
Neurobiol Aging; 2012 Jul; 33(7):1481.e7-12. PubMed ID: 22221884
[TBL] [Abstract][Full Text] [Related]
43. Gene mutations in a Han Chinese Alzheimer's disease cohort.
Ma L; Zhang J; Shi Y; Wang W; Ren Z; Xia M; Zhang Y; Yang M
Brain Behav; 2019 Jan; 9(1):e01180. PubMed ID: 30549411
[TBL] [Abstract][Full Text] [Related]
44. Exome sequencing identifies 2 novel presenilin 1 mutations (p.L166V and p.S230R) in British early-onset Alzheimer's disease.
Sassi C; Guerreiro R; Gibbs R; Ding J; Lupton MK; Troakes C; Lunnon K; Al-Sarraj S; Brown KS; Medway C; Lord J; Turton J; Mann D; Snowden J; Neary D; Harris J; Bras J; ; Morgan K; Powell JF; Singleton A; Hardy J
Neurobiol Aging; 2014 Oct; 35(10):2422.e13-6. PubMed ID: 24880964
[TBL] [Abstract][Full Text] [Related]
45. Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer's disease.
Shinohara M; Fujioka S; Murray ME; Wojtas A; Baker M; Rovelet-Lecrux A; Rademakers R; Das P; Parisi JE; Graff-Radford NR; Petersen RC; Dickson DW; Bu G
Brain; 2014 May; 137(Pt 5):1533-49. PubMed ID: 24625695
[TBL] [Abstract][Full Text] [Related]
46. A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Aβ42/Aβ40 ratio.
Qiu Q; Shen L; Jia L; Wang Q; Li F; Li Y; Jia J
J Alzheimers Dis; 2019; 69(1):199-212. PubMed ID: 30958370
[TBL] [Abstract][Full Text] [Related]
47. Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
O'Connor A; Pannee J; Poole T; Arber C; Portelius E; Swift IJ; Heslegrave AJ; Abel E; Willumsen N; Rice H; Weston PSJ; Ryan NS; Polke JM; Nicholas JM; Mead S; Wray S; Chávez-Gutiérrez L; Frost C; Blennow K; Zetterberg H; Fox NC
Brain; 2021 Nov; 144(10):2964-2970. PubMed ID: 33892504
[TBL] [Abstract][Full Text] [Related]
48. Autosomal dominant early onset Alzheimer's disease in the Mexican state of Jalisco: High frequency of the mutation PSEN1 c.1292C>A and phenotypic profile of patients.
Dumois-Petersen S; Gallegos-Arreola MP; Magaña-Torres MT; Perea-Díaz FJ; Ringman JM; Figuera LE
Am J Med Genet C Semin Med Genet; 2020 Dec; 184(4):1023-1029. PubMed ID: 33274538
[TBL] [Abstract][Full Text] [Related]
49. [Alzheimer disease: autosomal dominant forms].
Guyant-Maréchal L; Campion D; Hannequin D
Rev Neurol (Paris); 2009 Mar; 165(3):223-31. PubMed ID: 19081588
[TBL] [Abstract][Full Text] [Related]
50. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.
Ryan NS; Biessels GJ; Kim L; Nicholas JM; Barber PA; Walsh P; Gami P; Morris HR; Bastos-Leite AJ; Schott JM; Beck J; Mead S; Chavez-Gutierrez L; de Strooper B; Rossor MN; Revesz T; Lashley T; Fox NC
Neurobiol Aging; 2015 Dec; 36(12):3140-3151. PubMed ID: 26410308
[TBL] [Abstract][Full Text] [Related]
51. Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer's disease.
Vöglein J; Paumier K; Jucker M; Preische O; McDade E; Hassenstab J; Benzinger TL; Noble JM; Berman SB; Graff-Radford NR; Ghetti B; Farlow MR; Chhatwal J; Salloway S; Xiong C; Karch CM; Cairns N; Mori H; Schofield PR; Masters CL; Goate A; Buckles V; Fox N; Rossor M; Chrem P; Allegri R; Ringman JM; Höglinger G; Steiner H; Dieterich M; Haass C; Laske C; Morris JC; Bateman RJ; Danek A; Levin J;
Brain; 2019 May; 142(5):1429-1440. PubMed ID: 30897203
[TBL] [Abstract][Full Text] [Related]
52. Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
Hausner L; Tschäpe JA; Schmitt HP; Hentschel F; Hartmann T; Frölich L
Alzheimers Dement; 2014 Mar; 10(2):e27-39. PubMed ID: 23850332
[TBL] [Abstract][Full Text] [Related]
53. Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease.
Chen HH; Eteleeb A; Wang C; Fernandez MV; Budde JP; Bergmann K; Norton J; Wang F; Ebl C; Morris JC; Perrin RJ; Bateman RJ; McDade E; Xiong C; Goate A; Farlow M; Chhatwal J; Schofield PR; Chui H; Harari O; Cruchaga C; Ibanez L;
Acta Neuropathol Commun; 2022 Mar; 10(1):29. PubMed ID: 35246267
[TBL] [Abstract][Full Text] [Related]
54. Unexpected partial correction of metabolic and behavioral phenotypes of Alzheimer's APP/PSEN1 mice by gene targeting of diabetes/Alzheimer's-related Sorcs1.
Knight EM; Ruiz HH; Kim SH; Harte JC; Hsieh W; Glabe C; Klein WL; Attie AD; Buettner C; Ehrlich ME; Gandy S
Acta Neuropathol Commun; 2016 Feb; 4():16. PubMed ID: 26916443
[TBL] [Abstract][Full Text] [Related]
55. Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database.
Ringman JM; Monsell S; Ng DW; Zhou Y; Nguyen A; Coppola G; Van Berlo V; Mendez MF; Tung S; Weintraub S; Mesulam MM; Bigio EH; Gitelman DR; Fisher-Hubbard AO; Albin RL; Vinters HV
J Neuropathol Exp Neurol; 2016 Mar; 75(3):284-90. PubMed ID: 26888304
[TBL] [Abstract][Full Text] [Related]
56. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
[TBL] [Abstract][Full Text] [Related]
57. Identification of PSEN1 and APP gene mutations in Korean patients with early-onset Alzheimer's disease.
Park HK; Na DL; Lee JH; Kim JW; Ki CS
J Korean Med Sci; 2008 Apr; 23(2):213-7. PubMed ID: 18437002
[TBL] [Abstract][Full Text] [Related]
58. Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland.
Zekanowski C; Styczyńska M; Pepłońska B; Gabryelewicz T; Religa D; Ilkowski J; Kijanowska-Haładyna B; Kotapka-Minc S; Mikkelsen S; Pfeffer A; Barczak A; Łuczywek E; Wasiak B; Chodakowska-Zebrowska M; Gustaw K; Łaczkowski J; Sobów T; Kuźnicki J; Barcikowska M
Exp Neurol; 2003 Dec; 184(2):991-6. PubMed ID: 14769392
[TBL] [Abstract][Full Text] [Related]
59. Clinical Phenotype and Mutation Spectrum of Alzheimer's Disease with Causative Genetic Mutation in a Chinese Cohort.
Mao C; Li J; Dong L; Huang X; Lei D; Wang J; Chu S; Liu C; Peng B; Román GC; Cui L; Gao J
Curr Alzheimer Res; 2021; 18(3):265-272. PubMed ID: 34102969
[TBL] [Abstract][Full Text] [Related]
60. A mutation screening by DHPLC of PSEN1 and APP genes reveals no significant variation associated with the sporadic late-onset form of Alzheimer's disease.
Scacchi R; Gambina G; Moretto G; Corbo RM
Neurosci Lett; 2007 May; 418(3):282-5. PubMed ID: 17412506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
